Rebiotix Inc.
Roseville, MN · Founded 2011 · CIK 0001532997 · Biotech · Acquired
Live biotherapeutic drug derived from donated stool microbiota for treating C. difficile infection and related diseases
giveacrapmn.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $29M
- 3 Form D · Sep 2017
- 109 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 34 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112012201320142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,780,000 | |
| Private capital raised | Form D · SEC | $18,000,000 | |
| Private capital raised | Form D · SEC | $8,515,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2130 | CASI Pharmaceuticals, Inc. | — | $35M |
| 2131 | BLUE THERAPEUTICS, INC. | — | — |
| 2132 | ProteoPrinceps, LLC | — | — |
| 2133 | Rebiotix Inc. | — | $29M |
| 2134 | Mahzi Therapeutics Inc. | — | $27M |
| 2135 | INVIVO THERAPEUTICS HOLDINGS CORP. | — | $9.3M |
| 2136 | Richard Fisher | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael BermanDirector
- Greg FluetExecutive Officer
- Lee JonesDirector · Executive Officer
- Erwin KelenDirector
- William McGuireDirector
- Nancy TimmExecutive Officer
Patents
- Bacteriotherapy For Clostridium Difficile Colitisgranted
- Bacteriotherapy For Clostridium Difficile Colitisgranted
- Microbiota Restoration Therapy (mrt), Composition And Methods Of Manufacturegranted
- Microbiota Restoration Therapy (mrt) Compositions And Methods Of Manufacturegranted
- Bacteriotherapy For Clostridium Difficile Colitisgranted
- Bacteriotherapy For Clostridium Difficile Colitisgranted
- Microbiota Restoration Therapy (mrt) Compositions And Methods Of Manufacturegranted
- Microbiota Restoration Therapy (mrt) Compositions And Methods Of Manufacturegranted
- Microbiota Restoration Therapy (mrt), Compositions And Methods Of Manufacturegranted
- Bacteriotherapy For Clostridium Difficile Colitisgranted
- Microbiota Restoration Therapy (mrt) Compositions And Methods Of Manufacturegranted
- Microbiota Restoration Therapy (mrt) Compositions And Methods Of Manufacturegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.